Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS have higher levels of certain androgens, which are good at predicting excess hair growth.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.

The research found that measuring androgens in urine can give extra information about body metabolism and is linked to androgen levels in the blood, especially in young girls.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Androstenedione is better than testosterone for diagnosing PCOS in Indian women.

Finasteride safely lowers DHT levels without affecting testosterone.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

Polycystic ovarian shape is a genetic sign of PCOS and its hormonal and metabolic features can be inherited.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

Cyproterone acetate is effective for treating hirsutism and acne but less so for hair loss, with side effects similar to birth control pills.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

High levels of male hormones are very common in women with PCOS and affect their metabolism differently depending on their weight.

Women with hair loss had higher levels of certain hormones, suggesting a link to a condition like PCOS.

Some supplements and hormones can increase hair loss by raising DHT levels.

A thorough diagnostic process and teamwork are crucial for managing complex hyperandrogenism in postmenopausal women.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

Epitestosterone may counteract testosterone's effects and has roles in body processes like prostate growth and hair distribution.

Long-term use of finasteride in women can cause hormonal changes, DNA damage, and menstrual issues.

Rat skin takes up and processes testosterone differently than other organs, with testosterone being more important for the skin than its metabolite 5α-DHT.

High testosterone levels in 20% of the women studied may indicate PCOS, while 80% had low levels with potential health impacts.

Testosterone and dihydrotestosterone play a role in women's health issues like excess hair and baldness, and treatments blocking these hormones may help.

A 5 mg dose of transdermal testosterone cream effectively restores testosterone levels in postmenopausal women.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Diagnosing PCOS in teenagers should focus on signs of excess male hormones and not rely solely on ovarian ultrasound or irregular periods, and should be reassessed in adulthood.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.